Ad
related to: new england medical journal covid
Search results
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 2 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season,...
CAR T-Cell Therapy Could Be A Gamechanger For Autoimmune Diseases
Forbes· 1 day agoA recent study in the New England Journal of Medicine grabbed the attention of the medical community...
Personalized Microbiome-Based Diet Shows Promise for IBS
Medscape· 3 hours agoNew research highlighted the potential of a personalized microbiome-based diet, created using the...
Opinion | 'Still Haunted By His Pleas to Get Out of There': What We Heard This Week
MedPage Today· 5 days ago"I'm still haunted by his pleas to get out of there." -- Felice Freyer, president of the Association...
Monoclonal Antibody May Benefit Patients With Kidney Transplant Rejection
MedPage Today· 3 days agoOriginally developed for multiple myeloma, felzartamab is a fully human IgG1 monoclonal CD38...
Scientists Decode Deadly Blood Clot Disorder Triggered by COVID Vaccines
SciTechDaily· 4 days agoNew research has shown that the dangerous PF4 antibodies involved in vaccine-induced thrombosis...
5 Magnificent Stocks Being Bought for Warren Buffett's $646 Million "Secret" Portfolio
Motley Fool via Yahoo Finance· 4 days agoWarren Buffett's secret portfolio contains 90 securities -- five of which are phenomenal businesses...
Antinephrin Autoantibodies: Biomarker for Kidney Disease?
Medscape· 5 days agoUsing an innovative analysis technique, researchers identified antinephrin autoantibodies as markers...
Dupilumab Improves Outcomes in COPD With Type 2 Inflammation
Medscape· 3 days agoNew trial confirmed safety and efficacy of a subcutaneous add-on therapy for uncontrolled COPD.
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 11 hours agoOncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that favorable data regarding its lead product VitaGraft™ Kidney was published in the New
